Funding for this research was provided by:
National Natural Science Foundation of China (82200961)
the Science and Technology Commission of Shanghai (20DZ2270800)
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology (2022SKLE-KFKT004)
China Postdoctoral Science Foundation (2022M720091)
Article History
Received: 14 April 2024
Accepted: 21 June 2024
First Online: 1 July 2024
Declarations
:
: Written informed consent was obtained from all patients in accordance with the Declaration of Helsinki. This study was approved by the Human Ethics Committee of Ninth People’s Hospital (Shanghai JiaoTong University School of Medicine, Shanghai, China). All experiments on the participants in this study were performed in accordance with the relevant guidelines and regulations.
: The authors declare that they have no competing interests in this section.